Medication Knowledge of Patients with Parkinson's Disease: Strengths and Gaps [0.03%]
帕金森病患者的用药知识：优势与不足
Stephan Greten,Sarana Ulaganathan,Johannes Heck et al.
Stephan Greten et al.
Background: Effective drug treatment of motor and non-motor symptoms in Parkinson's disease (PD) often requires the administration of several anti-Parkinson drugs in complex treatment regimens. The successful autonomous a...
Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review [0.03%]
帕金森病患者深部脑刺激手术后的影像学改变：文献综述
Suraiya Mangra,Stanislaw Szlufik,Chao-Kai Hu et al.
Suraiya Mangra et al.
Background: Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the mi...
Effects of Deep Brain Stimulation and Botulinum Toxin to Manage Pisa Syndrome in Parkinson's Disease [0.03%]
用于治疗帕金森病pisah症的深部脑刺激与肉毒杆菌毒素的效果
Thiago Martins da Silva,Maria Fernanda Liphaus Almeida Negreli,Francisco Eduardo Costa Cardoso
Thiago Martins da Silva
Background: Pisa Syndrome (PS) is an abnormal postural deformity characterized by lateral trunk flexion leading to significant disability in patients with Parkinson's disease (PD). Botulinum toxin (BTX) and deep brain sti...
Complementary and Integrative Medicine for the Treatment of Tourette's Syndrome [0.03%]
用于治疗抽动症的补充和整合医学
Tamara Pringsheim,Catherine Deans,Saar Anis et al.
Tamara Pringsheim et al.
Background: There is widespread interest in complementary and integrative medicine (CIM) among people with Tourette's syndrome (TS). Objective: ...
Documented End-of-Life Preferences of People With Parkinson's Disease or Parkinsonism Across Europe [0.03%]
欧洲帕金森病或帕金森氏症患者的书面生命末期意愿通知书
Bauke W Dijkstra,Catharina Muente,Michela Garon et al.
Bauke W Dijkstra et al.
Background: Parkinson's disease and atypical parkinsonism are characterized by motor and non-motor symptoms. As the disease advances, planning for end-of-life (EoL) care becomes increasingly important. However, consensus-...
Persistent Head Tremor Improvement in Essential Tremor Patients after Bilateral Ventral Intermediate Nucleus DBS [0.03%]
双侧丘脑腹内侧核DBS治疗原发性震颤患者头部持续性震颤改善疗效分析
Maxime Munyeshyaka,Janine Hsu,Nymisha Mandava et al.
Maxime Munyeshyaka et al.
Moving Ear and Headache: A Case Report and Discussion of Similarities with the Painful Leg and Moving Toes Syndrome [0.03%]
动耳和头痛：一例报道及其与痛苦的腿和动趾综合征相似性的讨论
Yannick Fogoum Fogang,Paul Cedric Chimi Mbonda,Joseph Kamtchum-Tatuene et al.
Yannick Fogoum Fogang et al.
Case Reports
Movement disorders clinical practice. 2025 Dec 3. DOI:10.1002/mdc3.70471 2025
Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review [0.03%]
与22q11.2微缺失相关的运动障碍：一项综述研究
Nikolai Gil D Reyes,Daniel G Di Luca,Connie Marras et al.
Nikolai Gil D Reyes et al.
Background: Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. ...
Modafinil-Induced Hyperkinetic Movements in Post-Stroke Patients: A Case Series [0.03%]
阿莫达非尼致卒中后患者hyperkinetic运动障碍的病例报告系列论文
Mahendra Javali,Anish Mehta,Chandrashekhar Enuguri et al.
Mahendra Javali et al.
Background: Modafinil is a wakefulness-promoting agent used off-label for post-stroke hypersomnolence. Although generally well-tolerated, rare central nervous system adverse effects, including hyperkinetic movement disord...
Late-Onset, Slowly Progressive Pure Cerebellar Ataxia Associated with a Homozygous Missense Variant in PNPLA6 [0.03%]
PNPLA6错义突变所致成人起病进行性小脑共济失调一例报告
Agustín Querejeta-Coma,Almudena Avila-Fernandez,Laura Santos Sánchez de Las Matas et al.
Agustín Querejeta-Coma et al.